These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29314171)

  • 1. Vogt-Koyanagi-Harada disease-like uveitis induced by vemurafenib for metastatic cutaneous malignant melanoma.
    Fusumae T; Kamiya K; Maekawa T; Komine M; Murata S; Inoda S; Takahashi R; Kawashima H; Ohtsuki M
    J Dermatol; 2018 Jun; 45(6):e159-e160. PubMed ID: 29314171
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
    Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
    Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
    [No Abstract]   [Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04.
    Amagai R; Fujimura T; Yamazaki E; Takahashi M; Tamabuchi E; Kambayashi Y; Hashimoto A; Hashimoto K; Asano Y
    J Dermatol; 2024 Jun; 51(6):854-857. PubMed ID: 38111371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
    Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
    Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
    Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
    Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone.
    Witmer MT
    Ophthalmic Surg Lasers Imaging Retina; 2017 Nov; 48(11):928-931. PubMed ID: 29121363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.
    Fujimura T; Kambayashi Y; Tanita K; Sato Y; Hidaka T; Otsuka A; Tanaka H; Furudate S; Hashimoto A; Aiba S
    J Dermatol; 2018 Jun; 45(6):735-737. PubMed ID: 29488243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VOGT-KOYANAGI-HARADA-LIKE UVEITIS FOLLOWED BY MELANOMA-ASSOCIATED RETINOPATHY WITH FOCAL CHORIORETINAL ATROPHY AND CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH METASTATIC CUTANEOUS MELANOMA.
    Ng CC; Alsberge JB; Qian Y; Freund KB; Cunningham ET
    Retin Cases Brief Rep; 2023 Jan; 17(1):18-22. PubMed ID: 33394953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Ipilimumab-induced Multisystem Autoimmune-like Toxicities Suggestive of Vogt-Koyanagi-Harada-like Syndrome.
    Monferrer-Adsuara C; Hernández-Bel L; Hernández-Garfella ML; Remolí-Sargues L; Ortiz-Salvador M; Castro-Navarro V; Cervera-Taulet E
    Optom Vis Sci; 2021 Nov; 98(11):1309-1316. PubMed ID: 34510146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal Imaging Approach in a Patient with Vogt-Koyanagi-Harada-like Syndrome Due to Dabrafenib and Trametinib Use for Cutaneous Melanoma.
    Bellanca RF; Pinna A; Catania G; Belcastro E; Angi M; D'Amico Ricci G
    Ocul Immunol Inflamm; 2023 Feb; 31(2):402-406. PubMed ID: 35113757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
    Madoe A; Schauwvlieghe PP; Jacob J
    Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
    Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
    Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Vogt-Koyanagi-Harada disease and impressive response to immune checkpoint blockade in metastatic melanoma.
    Gambichler T; Seifert C; Lehmann M; Lukas C; Scheel C; Susok L
    Immunotherapy; 2020 May; 12(7):439-444. PubMed ID: 32308086
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vogt-Koyanagi-Harada syndrome in the setting of vemurafenib therapy for metastatic melanoma: a case report].
    Ren XT; Guo T; Yang F; Wu WY; Dou HL; Li XM
    Zhonghua Yan Ke Za Zhi; 2022 Nov; 58(11):925-928. PubMed ID: 36348532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoid-like Granulomatous Intraocular Inflammation Caused by Vemurafenib Treatment for Metastatic Melanoma.
    Eser Öztürk H; Süllü Y
    Turk J Ophthalmol; 2020 Mar; 50(1):50-52. PubMed ID: 32167264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient.
    Arai T; Harada K; Usui Y; Irisawa R; Tsuboi R
    J Dermatol; 2017 Aug; 44(8):975-976. PubMed ID: 27649838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma].
    Mihailovic N; Dyballa J; Herz S; Fluck M; Alnawaiseh M; Merté RL; Eter N
    Ophthalmologe; 2020 May; 117(5):467-471. PubMed ID: 31489479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada disease-like posterior uveitis in the course of nivolumab (anti-PD-1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma.
    Matsuo T; Yamasaki O
    Clin Case Rep; 2017 May; 5(5):694-700. PubMed ID: 28469878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.
    Crosson JN; Laird PW; Debiec M; Bergstrom CS; Lawson DH; Yeh S
    J Immunother; 2015; 38(2):80-4. PubMed ID: 25658618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.